NICE recommends drug to slow sinus rhythm in heart failure
NICE has recommended that a drug to slow heart rate should be made available on the NHS to treat patients with chronic heart failure.
The draft appraisal recommends ivabradine is used in combination with ß-blockers in patients with chronic heart disease whose heart rate is over 75 beats per minute, or if ß-blocker therapy is contraindicated or not tolerated.
Ivabradine was previously only recommended for use in patients suffering from angina, but a study in 2010 showed the drug reduced the number of cardiovascular-related deaths or admissions by 18% in patients with heart failure.
Dr Terry McCormack, a GP in Whitby, said: ‘I am not surprised that NICE is recommending ivabradine in chronic heart failure, because evaluations have shown that it reduces the number of hospitalisations. It is a very safe drug that is effective both in angina and heart failure.
‘There are a substantial number of people who cannot tolerate ß-blockers – for example, people with asthma or those who experience fatigue. But there are also patients who even with the use of ß-blockers have a fast heart rate. For these people, both drugs may be necessary.'
Professor Carole Longson, health technology evaluation centre director at NICE, said: ‘Although the prognosis for people with heart failure has been improving over recent years, largely as a result of better treatments, heart failure can have a significant detrimental impact on quality of life, particularly in terms of affecting a person's ability to perform everyday tasks.'
Portfolio careers
What is the right portfolio career for you?
Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.
